Alex's Lemonade Stand Foundation’s Post

An intriguing commentary—lots of interesting points here. Although a well-crafted cover letter should be able to provide the customized narrative that targets the key focus areas of any specific job that someone is applying for. A mistake I see many people make is that they simply try to re-create their CV in narrative form in a cover letter—rather than use the letter as an opportunity to cherry pick some key areas for a deep dive that will highlight how well aligned they are for “that” specific job. I always tell my mentees to avoid a “copy/paste” approach to cover letters. Those letters are instantly recognizable and do not help you stand out (at least not in a positive light). Taking a customized approach serves as a great chance to show that you are putting careful thought into your application. It also allows the reader to see that you can think critically about how your skills and experiences align with their needs.

ATTENTION: Susan G. Komen RFA - ASPIRE GRANT - Applicants/Primary Investigators (PIs) may request funding of up to $100,000 per year to cover a trainee’s salary for one year or two years. - RFA Release Date: September 5, 2024 - Application Deadline: November 4, 2024 at 1:00pm ET ASPIRE grants are intended to enhance the diversity of the breast cancer research workforce by providing established breast cancer scientists with supplemental funding to support research trainees from communities historically minoritized and marginalized in research. A breast cancer research workforce that represents the breast cancer community is one way to work towards health equity and better outcomes for all. By supporting these promising trainees early in their research careers, Komen seeks to ensure that a diverse group of highly trained scientists who reflect the communities we serve will emerge as the next generation of leaders in breast cancer research and end breast cancer forever.  #grant #healthcare #healthequity #breastcancer

MIT Koch Institute for Integrative Cancer Research spans all stages of the research pipeline—from bench to bedside. Our researchers ask fundamental questions about basic biological processes and invent new technologies to address critical cancer challenges. Part of that research is done by scientists in the Convergence Scholars Program (CSP). These postdocs understand a broad range of disciplinary approaches, are able to ask creative questions, and are trained to answer those questions with diverse tools. In these series of lightning talks, these postdocs will tell you how they are preparing for life beyond the bench with CSP. RSVP: https://bit.ly/4cQ6sly

MIT Koch Institute for Integrative Cancer Research spans all stages of the research pipeline—from bench to bedside. Their researchers ask fundamental questions about basic biological processes and invent new technologies to address critical cancer challenges. Part of that research is done by scientists in the Convergence Scholars Program (CSP). These postdocs understand a broad range of disciplinary approaches, are able to ask creative questions, and are trained to answer those questions with diverse tools. In these series of lightning talks, these postdocs will tell you how they are preparing for life beyond the bench with CSP. RSVP: https://bit.ly/4cQ6sly

𝗖𝗮𝗻 𝘄𝗲 𝗺𝗮𝗸𝗲 𝗶𝘁 𝘂𝗽 𝘁𝗼 𝟱𝟬%? – 𝗢𝗻𝗹𝘆 3️⃣ 𝗺𝗼𝗿𝗲 𝗱𝗮𝘆𝘀 𝘁𝗼 𝗽𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝘁𝗲! #RaceTo50 Currently, the third N² Survey is taking place until the 19th of May. It's a joint survey assessing the working conditions of ~16,000 doctoral researchers at the large non-university research institutes – the Helmholtz-Gemeinschaft, Max Planck Society, and Leibniz-Gemeinschaft. 𝗔𝘀 𝘄𝗶𝘁𝗵 𝗮𝗹𝗹 𝘀𝘁𝘂𝗱𝘆 𝗿𝗲𝘀𝘂𝗹𝘁𝘀, 𝗮 𝗵𝗶𝗴𝗵 𝗹𝗲𝘃𝗲𝗹 𝗼𝗳 𝗽𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝘁𝗶𝗼𝗻 𝗶𝘀 𝗰𝗿𝘂𝗰𝗶𝗮𝗹! To ensure that the obtained results are representative, it is important that as many doctoral students as possible from all areas of #HelmholtzMunich participate in the survey. 𝗪𝗵𝘆 𝗶𝘀 𝘆𝗼𝘂𝗿 𝗽𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝘁𝗶𝗼𝗻 𝘀𝗼 𝗶𝗺𝗽𝗼𝗿𝘁𝗮𝗻𝘁 𝘁𝗼 𝘂𝘀? Your feedback is invaluable for us as it helps us to understand the current situation of doctoral researchers at Helmholtz Munich. It will enable us to identify areas where we can improve the conditions for our doctoral researchers – for 𝙮𝙤𝙪! ➡ 𝗟𝗶𝗻𝗸 𝘁𝗼 𝘁𝗵𝗲 𝘀𝘂𝗿𝘃𝗲𝘆: https://lnkd.in/dQg_M2TQ ⬅

🔬 DIPG RESEARCH UPDATE: With support from the Foundation's Early Career Fellowship $345,000 grant, Dr. Yolanda Colino Sanguino and her team at Children's Cancer Institute are advancing our understanding of how to treat Diffuse Intrinsic Pontine Glioma (DIPG). They are working on identifying targetable epigenetic vulnerabilities in DIPG, and their recent breakthrough, pinpointing a vulnerable enzyme in p300, signals promising strides toward more effective treatments. Learn more about their pioneering work here: https://lnkd.in/et2Kh2wq #ChildhoodCancer #DIPG #BrainCancerResearch #ResearchUpdate #Hope #CureBrainCancer

🌟 **Thrilled to Share My Journey as a Global Scholar-In-Training Awardee (GSITA) - 2024!** 🌟 Last year, I had the incredible opportunity to attend the **AACR Annual Meeting 2024** in San Diego as a recipient of the Global Scholar-In-Training Award (GSITA). It was an absolutely **mind-blowing experience**, and I wanted to share how this award changed my research journey. As a passionate research scholar, one of my dreams was to present my research on an international stage. Due to funding constraints, I could previously only participate virtually in international conferences. But things changed when I came across the **AACR GSITA**, which supports early-career researchers with travel grants to attend the annual meeting. I submitted my abstract, CV, and cover letter (statement of purpose) before the deadline, and soon after, I was notified that my abstract had been selected! This was a huge moment for me, and it got even better when I was awarded the GSITA grant—a **$2000 USD** award that covered travel, food, with complimentary accommodation, and conference registration. During the event, I met so many brilliant minds from across the globe—fellow awardees, top scientists, leaders from the pharmaceutical industry, and experts in cancer research. It was a once-in-a-lifetime experience that has deeply impacted my career. I even had the opportunity to meet the **President of AACR**, **editors of AACR journals**, and other leading figures in the field. If you're an early-career researcher in the cancer field, **this is your chance to apply** for the **AACR Global Scholar-In-Training Award for 2025**. Don't miss this opportunity—it's truly a game-changer for your professional journey! 🌐 🗓 **Key Dates:** - **Abstract Submission Deadline:** November 26, 2024 - **GSITA Application Deadline:** November 26, 2024 - **AACR Annual Meeting:** April 25-30, 2025, Chicago **Eligibility:** Early-career researchers building cancer research capacities in eligible countries. For more details, check out the attached flyer or visit **AACR.org/GSITA**. Feel free to reach out if you have any questions about the process! #AACR #GSITA #CancerResearch #PhDjourney #GlobalOpportunities #Networking #EarlyCareerResearchers --- You can tailor this further based on your style!

Thanks for the great article featuring David Johnson, PhD from the Invent@SC Program!

Impact In Action: Supporting Brain Cancer Researchers At Cure Brain Cancer Foundation, we're not just funding research; we're catalysing impact and driving action. Since 2017, we've invested nearly $2.5 million in Fellowships focused on adult and pediatric brain cancer; and with our new 5-Year Guardian Trust Early Career Fellowship, this investment will exceed $3 million. From early-career scientists bursting with fresh ideas to seasoned mid-career experts continuing to push boundaries, we're empowering researchers and fuelling their passion for finding a cure and building a foundation for groundbreaking discoveries. Visit our website to read about some of the amazing work our researchers are doing and how your support is making a difference: https://lnkd.in/duVyCH6G #ImpactInAction #CureBrainCancerFoundation #Fellowships #Research #BrainCancerAwarenessMonth

📢 Tune in for a new episode of Inside Cancer Careers! 🎙️ Jill Barnholtz-Sloan, PhD, discusses the importance of data science and informatics in cancer research, emphasizing the need for collaboration and data sharing. Listen now and discover how data science is revolutionizing cancer research! https://lnkd.in/eVdkPuAH #DataScience #CancerResearch